Pipeline Strategy

Optimize Return on New Pharmaceutical and Medical Products

Your pharmaceutical brands and medical products may not be generating returns that maximize your company’s substantial R&D and marketing investments. With market conditions creating higher barriers to commercial success, the pressures on R&D and marketing executives are becoming only more acute.

ZS helps life science companies increase the commercial success of their product pipelines. We help you determine what therapy areas to develop, what products in your portfolio will maximize your R&D investment and how to maximize sales through incorporating market input early in development.

Increase New Product Success, Decrease Disappointment

ZS’s Pipeline Strategy services helps you:

• Define the right criteria (including competitive threats), focus your disease area strategy, and evaluate risk and return to pursue the most lucrative product profiles
• Craft a viable commercial development strategy that increases the odds new products will exceed stakeholder needs
• Rapidly evaluate external product initiatives to improve business development and licensing (BD&L) strategy
• Incorporate market dynamics and needs into your R&D planning

• Create a portfolio strategy that balances risk and return for the short and long term

Why is ZS the Best Partner to Help Perfect the Product Pipeline?

• We have unparalleled expertise in life science marketing and in forecasting more than 150 therapy areas; we are intimately familiar with hundreds of pipeline initiatives worldwide
• ZS’s OPEN approach integrates market insights into the R&D pipeline, focusing R&D initiatives on the most promising candidates and indications
• Using rigorous quantitative models, ZS gives you a clear, accurate picture of the revenue potential and risk profile of new products
• ZS consultants have worked in senior positions in pharmaceutical marketing and R&D – they appreciate functional differences within an organization and can bridge cultural gaps